Journalist on drug importation: “There is a real risk.”

In this piece published in the Washington Free Beacon on April 25, 2019, staff writer Charles Fain Lehman explores issues around Florida’s drug importation proposal. “Critics,” he notes, “fear that the actual realities of regulatory oversight—especially in the hand of an as-yet-unnamed private vendor—will simply be too challenging to manage responsibly.”

[...]

Utah pharmacist and state senator: Importation raises “serious concerns about drug safety”

In this piece, which was published in The Deseret News on April 24, 2019, pharmacist and Utah State Senate Majority Leader Evan Vickers raises serious concerns about importation as a strategy to lower drug prices:

“Anyone who truly understands how drugs are sold and distributed in the U.S. knows that there are very solid technical reasons that such importation is not viable. There are also serious concerns about drug safety, since the CHS cannot guarantee origin and purity on foreign-sourced drugs.”

[...]

Politifact ignores the world of criminal counterfeiters

Politifact.com emailed us this week with questions about a recent ad about the dangers of attempting to import medicine from Canada. They labeled it negatively, but we noticed that they ignored certain facts while coming to their conclusion. In the interest of fairness, we’ve published below both the email from Politifact and our heavily sourced response. Judge for yourself if legislators in Florida are being naive about the risks of importation in a world with a highly evolved criminal counterfeit scheme.

[...]